National Institute of Diabetes and Digestive and Kidney Diseases (Nonalcoholic Steatohepatitis)
This division of the National Institutes of Health provides nonalcoholic steatohepatitis symptom, diagnosis, treatment and clinical trial information.
Your safety is our priority. Get COVID-19 vaccine news, find details on our virtual screenings and see steps we've taken to keep you safe at your in-office visits:
Find full details at our COVID-19 Resource Center.
Obtenga más información acerca del COVID-19, incluyendo las preguntas más frecuentes y una examen virtual gratis. Ver información del COVID-19 y información sobre la vacuna.
Our expert care for this disease means faster, safer and better treatments for you
Nonalcoholic fatty liver disease (NAFLD) involves increased fatty deposits in your liver tissue. These deposits can impair functioning. Often, you do not have symptoms until it progresses to a later stage.
At IU Health, our expert physicians can diagnose fatty liver disease in its early stages. We will monitor your condition, reduce your risk factors and prevent disease progression.
Two kinds of fatty liver disease exist:
Both kinds involve increased fatty deposits in your liver tissue. These both can impact proper function. Only NASH can progress to cirrhosis. Nearly one-third of Americans have a fatty liver unrelated to alcohol consumption. Alcohol-induced liver disease also causes fatty deposits in the liver.
You may have right upper abdominal pain. This comes from an increase in the size of your liver from fatty deposition. Often, people do not have any symptoms.
At IU Health, your physicians may use any number of tools to diagnose your condition. They may use:
Physicians most often detect nonalcoholic fatty liver disease through routine blood tests. In these tests, we check your liver function and liver enzymes. Your physician may prescribe this test as part of a regular physical exam.
If your physician suspects you have nonalcoholic fatty liver disease, imaging tests can provide the right information for a diagnosis. Tests such as a computed tomography (CT) scan and/or a magnetic resonance imaging (MRI) may be used.
This new technology allows for a quick scan of your liver and spleen. The test checks for stiffness in your liver tissue (cirrhosis) and fatty deposits. You and your physician receive immediate test results. Together, you can determine treatment options. If the scan shows fatty deposits with scarring, then you may need a biopsy.
Your physician can study your liver cells under a microscope to confirm NASH. This involves taking cells from your liver through a needle to determine if they show scarring and inflammation.
Two kinds of fatty liver disease exist:
Both kinds involve increased fatty deposits in your liver tissue. These both can impact proper function. Only NASH can progress to cirrhosis. Nearly one-third of Americans have a fatty liver unrelated to alcohol consumption. Alcohol-induced liver disease also causes fatty deposits in the liver.
You may have right upper abdominal pain. This comes from an increase in the size of your liver from fatty deposition. Often, people do not have any symptoms.
At IU Health, your physicians may use any number of tools to diagnose your condition. They may use:
Physicians most often detect nonalcoholic fatty liver disease through routine blood tests. In these tests, we check your liver function and liver enzymes. Your physician may prescribe this test as part of a regular physical exam.
If your physician suspects you have nonalcoholic fatty liver disease, imaging tests can provide the right information for a diagnosis. Tests such as a computed tomography (CT) scan and/or a magnetic resonance imaging (MRI) may be used.
This new technology allows for a quick scan of your liver and spleen. The test checks for stiffness in your liver tissue (cirrhosis) and fatty deposits. You and your physician receive immediate test results. Together, you can determine treatment options. If the scan shows fatty deposits with scarring, then you may need a biopsy.
Your physician can study your liver cells under a microscope to confirm NASH. This involves taking cells from your liver through a needle to determine if they show scarring and inflammation.
At IU Health, physicians have an advanced understanding of nonalcoholic fatty liver disease. This means faster, safer, better treatments and therapies for you. This can remove the need for invasive biopsies in some cases. It can preserve your liver function. We may use any number of the following treatments:
At IU Health, physicians have an advanced understanding of nonalcoholic fatty liver disease. This means faster, safer, better treatments and therapies for you. This can remove the need for invasive biopsies in some cases. It can preserve your liver function. We may use any number of the following treatments:
This division of the National Institutes of Health provides nonalcoholic steatohepatitis symptom, diagnosis, treatment and clinical trial information.
This division of the National Institutes of Health provides cirrhosis symptom, diagnosis, treatment and clinical trial information.
This group focuses on education, support and research for the prevention and treatment of liver diseases.
This institute lets you to search for Indiana clinical research studies in which you might participate.
This division of the National Institutes of Health provides nonalcoholic steatohepatitis symptom, diagnosis, treatment and clinical trial information.
This division of the National Institutes of Health provides cirrhosis symptom, diagnosis, treatment and clinical trial information.
This group focuses on education, support and research for the prevention and treatment of liver diseases.
This institute lets you to search for Indiana clinical research studies in which you might participate.